General Terms and Conditions ("GTCs")

1. General

1.1 Provider Identification; Scope

These General Terms and Conditions (hereinafter referred to as "GTCs") apply to the contract between you, the patient (hereinafter referred to as "you" or "patient"), and us, EQUIOM CAPITAL INVEST Sp.zo.o., ul. Jana Heweliusza 11 #811, 80-890 Gdańsk, Poland, represented by President Mag. Chem. Jeppe ERIKSEN, NIP (Tax Number): 8561763610, KRS (National Court Register Number): 0000248898, REGON: 320159129, E-Mail: [email protected] (hereinafter referred to as "MizeBody"), regarding the use of the online platform we operate at https://mizebody.me for telemedical treatment in connection with therapy using GLP-1 receptor agonists (hereinafter referred to as "GLP-1 medications"). On this platform, you can register and contact doctors registered there who are licensed in the European Union (hereinafter referred to as "Platform Doctor") and submit treatment requests to them. If the Platform Doctor you have chosen prescribes a GLP-1 medication, you may instruct MizeBody to forward the prescription for the GLP-1 medication (hereinafter referred to as "Prescription") stored in your patient account on the platform to a pharmacy of your choice registered on the platform (your "Preferred Pharmacy" – see Section 2.4). Remote treatment is provided only in medically justifiable individual cases in compliance with § 7 (4) MBO-Ä; the doctor informs you about the specific features and limitations of remote treatment and documents the treatment.

1.2 Consumers

The GTCs apply exclusively to consumers. A "consumer" within the meaning of § 13 of the German Civil Code (hereinafter "BGB") is any natural person who enters into a legal transaction for purposes that are predominantly outside their trade, business, or profession. An "entrepreneur" within the meaning of § 14 BGB, on the other hand, is a natural or legal person or a partnership with legal capacity who, when entering into a legal transaction, acts in the exercise of their trade, business, or profession.

1.3 Minimum Age of the Patient; Delivery Restriction

The use of any services offered on or through our platform requires that you use the services exclusively for yourself, that you are at least 18 years old, have a residence in Germany, and are either self-paying or privately insured. We do not settle accounts with your statutory health insurance provider.

1.4 Version of the GTCs

The GTCs apply exclusively and in their current version valid at the time you use the platform, which can be accessed online at any time at https://mizebody.me. We do not recognize any general terms and conditions that conflict with or deviate from the GTCs, unless we expressly agree to their validity in writing. MizeBody reserves the right to adjust its service offering with effect for the future, in particular taking into account the legal, statutory, case law, and/or technical situation. MizeBody will inform you in good time on the platform about any upcoming changes to the service offering.

2. Use of the Platform

A free user agreement in accordance with these GTCs between you and MizeBody is concluded as soon as you use the platform. You may not use the platform if you do not accept these GTCs. The use of the platform does not yet constitute an engagement of our services; i.e., at this stage no mediation of medical services takes place.

2.1 General Conditions

2.1.1 Availability of the Platform

Uninterrupted and complete availability of the platform cannot be guaranteed according to the current state of technology. Therefore, MizeBody is not liable for the constant and uninterrupted error-free availability of the platform. Disruptions or maintenance work may limit or temporarily interrupt its use. Where MizeBody has influence over interruptions (e.g., during maintenance), MizeBody will endeavor to keep such interruptions as brief as possible. The platform can best be accessed using a personal computer (PC) via a web browser on the Internet, preferably through DSL, fiber optic, or an equivalent connection. If accessed via other internet-capable devices, such as smartphones or tablets, both functionality and display may be limited. The content on the platform is created with the greatest possible care. However, MizeBody does not guarantee the accuracy, completeness, or timeliness of the content provided on the platform. Likewise, MizeBody does not guarantee data security outside its sphere of control, nor protection from data loss during data transmission over the Internet. Links provided on the platform are not adopted as MizeBody's own. MizeBody is only liable for data loss in accordance with Section 3 if such loss could not have been avoided by you through appropriate data backup measures.

2.1.2 Platform Security

In providing the platform, MizeBody will implement suitable organizational and technical measures consistent with the current state of best practices to ensure the availability, integrity, authenticity, and confidentiality of the information systems, components, and processes used by MizeBody (collectively referred to as "Platform Security"). In particular, MizeBody ensures that a) video consultations conducted via the platform comply with suitable technical and organizational measures for data protection and data security that substantively meet the requirements of Annex 31b to the BMV-Ä; and b) patient data is transmitted or processed only in encrypted form. When using systems under MizeBody's control, MizeBody will impose corresponding obligations on its contractual partners and regularly monitor compliance. MizeBody will also perform regular data backups to the necessary extent.

2.1.3 Harmful and Overloading Use

You must refrain from any actions that could endanger platform security. In using the platform, you agree neither to use yourself nor permit a third party to use any tool, software, or routine to store, transmit, or introduce anything that interferes with or attempts to interfere with the proper functioning of the platform and the servers used by MizeBody (hereinafter referred to as "Servers"). In particular, you agree not to use or allow the use of devices, software, or routines that could disrupt the proper functioning of the platform and servers, and not to take any actions that create an unnecessary or disproportionately large burden on the platform and servers.

2.1.4 Copyright

Images, photos, films, and texts published on the platform are protected by copyright. Their use is not permitted without the express prior written consent of the respective rights holder.

2.1.5 Patient’s Own Content

(1) Where platform functions allow or expect you to upload or enter your own content such as texts, photos, videos, or other materials (hereinafter collectively referred to as "Own Content"), this may only be done in accordance with the technical specifications provided by MizeBody and via the specified communication channels; for example, file formats and sizes specified by MizeBody must be adhered to. (2) You guarantee MizeBody that you hold all rights in relation to your Own Content (including, in particular, copyright and related rights, industrial property rights such as trademark rights, and personality rights, especially image rights of third parties), to the extent necessary for MizeBody’s provision of services or exercise of rights. (3) For Own Content you upload or enter into your patient account, you grant MizeBody a simple, non-transferable, and time-limited right of use for the duration of this user agreement, insofar as this is necessary for MizeBody to provide the contractual services. This right particularly includes storing the content as well as forwarding it to the Platform Doctor you have selected for the initiation and execution of treatment, and to your Preferred Pharmacy for the transmission of a prescription.

2.2 Treatment Process

To receive telemedical treatment for a therapy with GLP-1 medications from one of the Platform Doctors, you must register a patient account and submit a treatment request via the appointment booking function on the platform to the Platform Doctor of your choice in accordance with the following regulations.

2.2.1 Registration of a Patient Account

(1) To submit treatment requests, you must first register a patient account (hereinafter "Patient Account") with MizeBody by providing the personal data marked as mandatory and declaring your electronic consent to these GTCs and MizeBody’s privacy policy. (2) You are obliged to provide complete and correct information when registering your Patient Account. Any information beyond the mandatory fields is voluntary. Once your Patient Account is activated, you can log in using the email address provided during registration and the password you chose (together "Access Data") and manage your account independently. You may not rent or lend your Patient Account. There is no entitlement to be granted access. Your Patient Account is non-transferable, and you may not create more than one account. (3) You are solely responsible for the security of your Access Data, including keeping it strictly confidential and not disclosing it to third parties. If your Access Data becomes known to unauthorized persons, you must immediately change your password at a minimum. MizeBody assumes no liability for any damages related to stolen Access Data, its disclosure, or the fact that you have granted a third party access to your Patient Account. You must immediately inform MizeBody of any unauthorized use of your Access Data and promptly notify any changes in your information via email. (4) Your Patient Account is valid for an indefinite period. You can deactivate it by submitting a request in text form (e.g., by email) to MizeBody’s customer service. Your Patient Account will then be deactivated. This action is irreversible but does not affect the validity of the user agreement. In particular, any payment obligations toward the Platform Doctor at the time of deactivation remain unaffected.

2.2.2 Treatment Requests

2.2.2.1 Questionnaire

(1) As a self-paying or privately insured patient, you may submit digital treatment requests for GLP-1 medication treatment (hereinafter "Treatment Request(s)") exclusively via the platform after registering a Patient Account with MizeBody and using the appointment booking function to contact the Platform Doctor of your choice. (2) The Treatment Request consists of an electronic medical questionnaire (hereinafter "Questionnaire") where you describe your medical needs and answer medically relevant questions required by the Platform Doctor (e.g., previous illnesses), along with other mandatory personal information and payment details. In the Questionnaire, you can provide information about your complaints and other relevant details for the Platform Doctor.

2.2.2.2 Fee; Mediation Agreement

During the Treatment Request process, you select one of the available Platform Doctors presented by MizeBody to begin treatment. After paying MizeBody a fee (hereinafter "Fee") for the Treatment Request (Section 2.2.4 of these GTCs), MizeBody immediately forwards the Treatment Request—initiated by clicking "Submit Treatment Request with Payment"—to the Platform Doctor you selected. Upon submission of the Treatment Request, a paid mediation agreement between you and MizeBody is concluded. The subject of this agreement is the forwarding of your binding Treatment Request to the selected Platform Doctor to conclude a treatment contract (Section 2.2.3). The aforementioned Fee is payable for this mediation service.

2.2.2.3 Pre-Qualification

(1) The Platform Doctor you selected reviews whether you pre-qualify for the desired GLP-1 medication treatment ("Pre-Qualification"), i.e., whether the Treatment Request appears medically justifiable based on your answers in the Questionnaire. During this initial evaluation, the Platform Doctor assesses whether remote treatment is feasible. Medically relevant information is evaluated in light of specific indications and contraindications for GLP-1 therapy and your suitability for such treatment. (2) If you pre-qualify based on your answers in the Questionnaire, the Platform Doctor contacts you, for example, by phone or sends an invitation via the platform to a personal video consultation (hereinafter "VC") to conduct the remote treatment. "Remote treatment" in the context of these GTCs refers to further anamnesis, diagnosis, and any subsequent remote prescription of GLP-1 medications for therapeutic purposes within the telemedical consultation, e.g., by phone or video consultation.

2.2.3 Conclusion of the Treatment Contract

(1) MizeBody does not provide medical services itself. The treatment contract is exclusively concluded between the Platform Doctor and you as the patient. MizeBody supports the Platform Doctor in conducting remote treatment and managing data and claims by providing the platform. Your free choice of Platform Doctor and the doctor’s independence are always ensured. (2) Treatment begins either in the doctor’s office or via remote treatment, at which point a treatment contract is concluded between you and the Platform Doctor, and you owe the treatment fee to the Platform Doctor (Section 2.3). The contract is exclusively between you and the treating Platform Doctor. (3) The treatment contract requires successful pre-qualification. If pre-qualification fails due to incorrect answers in the Questionnaire or other information provided in the Treatment Request, the Platform Doctor may refrain from remote treatment. (4) Treatment occurs at the doctor’s office or online via video consultation if deemed appropriate by the doctor. The Platform Doctor independently chooses the suitable diagnostic or therapeutic method. (5) The Platform Doctor will immediately terminate remote treatment if it cannot be properly conducted for reasons beyond their control, e.g., poor digital transmission quality, patient inability to participate, or other factors preventing professional standards.

2.2.4 Fee

(1) You pay MizeBody a fee of currently €19.79 for each Treatment Request, which MizeBody will refund if you are deemed unsuitable for remote treatment based on the Questionnaire or if you validly withdraw the Treatment Request. (2) If remote treatment takes place, the fee you paid will be credited toward the Platform Doctor’s charges.

2.2.5 Issuance of Prescriptions

Prescriptions issued to you by the treating Platform Doctor during your treatment are made available in your Patient Account for forwarding by us to a Platform Pharmacy of your choice (Section 2.4). MizeBody reserves the right not to provide any additional documents.

2.2.6 Patient Obligations During Treatment

2.2.6.1 Questionnaire

To avoid health risks, you are required to answer the Questionnaire and any medical follow-up questions from MizeBody and the treating Platform Doctor truthfully and completely, including questions about your current health, pre-existing conditions, medications you may be taking, and other personal circumstances. If you cannot answer fully and truthfully, you must refrain from submitting a Treatment Request.

2.2.6.2 Requirements for Remote Treatment

In addition to Section 2.1, you must ensure that you have the technical equipment required for remote treatment, including a computer or smartphone with a sufficiently high-resolution camera (at least HD = 1280×720 pixels) and microphone, as well as a fast and stable internet connection, and that appropriate conditions for remote treatment are provided (adequate lighting, quiet environment).

2.2.7 Consumer Withdrawal Rights

(1) As a consumer (Section 1.2), you have a statutory right of withdrawal when concluding distance contracts, about which we inform you below in our own name as well as in the name of the platform doctor in accordance with the statutory model (Section 2.2.7.1). Section 2.2.7.3 contains a sample withdrawal form. In Section 2.2.7.2 we inform you about the premature expiration of your withdrawal rights. (2) We act as the recipient for your withdrawal declaration vis-à-vis the platform doctor. If you effectively withdraw from the intermediary contract concluded with us, you are simultaneously no longer bound by the treatment contract concluded with the platform doctor.

2.2.7.1 Withdrawal Information – Intermediary Contract and Treatment Contract

You have a right of withdrawal with respect to the intermediary contract concluded with us and the treatment contract concluded with the platform doctor, about which we inform you in our own name and in the name of the platform doctor as follows: Withdrawal Information You have the right to withdraw from this contract within fourteen days without giving any reason. The withdrawal period is fourteen days from the conclusion of the contract. To exercise your right of withdrawal, you must inform us or the platform doctor, to our attention: EQUIOM CAPITAL INVEST Sp.zo.o., ul. Jana Heweliusza 11 #811, 80-890 Gdansk, Poland, E-Mail: [email protected], of your decision to withdraw from this contract by means of a clear statement (e.g., a letter sent by post, fax, or e-mail). You may use the attached sample withdrawal form, but this is not mandatory. To meet the withdrawal deadline, it is sufficient that you send the notification of your exercise of the right of withdrawal before the withdrawal period expires. Effects of Withdrawal If you withdraw from this contract, we shall reimburse all payments received from you, including delivery costs (except for any additional costs arising from your choice of a delivery method other than the least expensive standard delivery offered by us), without undue delay and at the latest within fourteen days from the day on which we receive notification of your withdrawal from this contract. We will use the same means of payment for this reimbursement as you used for the original transaction, unless expressly agreed otherwise with you; in no case will you be charged fees for this reimbursement. If you requested that the services begin during the withdrawal period, you shall pay us an appropriate amount corresponding to the portion of the services already provided up to the time at which you informed us of your exercise of the right of withdrawal in comparison with the total scope of services provided for in the contract.

2.2.7.2 Premature Expiration of Consumer Withdrawal Rights

Your withdrawal rights expire prematurely if: we or the platform doctor have begun performing the service after you have given your express consent and at the same time confirmed your awareness that you will lose your right of withdrawal once the contract is fully performed by us or the platform doctor, and we or the platform doctor have fully performed the services.

2.2.7.3 Sample Withdrawal Form

We inform you about the sample withdrawal form in our own name and in the name of the platform doctor as follows: Sample Withdrawal Form (If you want to withdraw from the contract, please fill out this form and return it.) EQUIOM CAPITAL INVEST Sp.zo.o. Jana Heweliusza 11 #811 80-890 Gdansk Poland E-Mail: [email protected] I/We (*) hereby withdraw from the contract concluded by me/us (*) for the purchase of the following goods (*)/the provision of the following service (*) ___________________________________________ Ordered on (*) ___________________________________________ Received on (*) ___________________________________________ Name of consumer(s) ___________________________________________ Address of consumer(s) ___________________________________________ Signature of consumer(s) (only if this form is submitted on paper) ___________________________________________ Date (*) Delete as applicable

2.2.8 Medical Providers

An overview of the Platform Doctors and Platform Pharmacies currently registered on the platform, from which you may generally choose freely, is provided in the Treatment Request flow. Please note that depending on platform workload and the scheduling of the respective Platform Doctor, a doctor may not always be available at all times.

2.3 Costs

2.3.1 Payment Processing; Fee Offset

(1) Medical services are billed to you by the treating Platform Doctor in accordance with the German Medical Fee Schedule ("GOÄ"). (2) The fee you have paid is offset against the GOÄ fees. (3) The use of the platform itself (including forwarding your prescription to a Platform Pharmacy of your choice) is free of charge for you.

2.3.2 Invoicing

Invoicing for medical services occurs immediately after their provision. For this purpose, MizeBody acts through a payment service provider appointed by MizeBody on behalf of the Platform Doctor.

2.4 Forwarding Your Prescriptions

(1) In your Patient Account, you can select a prescription issued by your treating Platform Doctor and stored in your Patient Account and, by clicking the button "Send Prescription to Pharmacy Now," instruct us to electronically forward the prescription free of charge to a pharmacy registered on the platform ("Platform Pharmacy") that you selected via the platform’s pharmacy search function using specific parameters of your choice (e.g., location) (hereinafter your "Preferred Pharmacy"). (2) Please note that the forwarding function via the "Send Prescription to Pharmacy Now" button only serves to forward your issued prescription to your Preferred Pharmacy in compliance with data protection and pharmacy law (e.g., to avoid duplicate redemption). No purchase contract with your Preferred Pharmacy is concluded via the platform. The purchase contract for GLP-1 medications prescribed to you is concluded exclusively and directly with your Preferred Pharmacy. We do not act as your agent or as the agent of your Preferred Pharmacy regarding declarations of intent related to such a purchase contract. Before clicking the "Send Prescription to Pharmacy Now" button, you are expected to inform yourself about the price, shipping costs, and the terms and conditions of sale/delivery regarding the prescribed GLP-1 medications from your Preferred Pharmacy. (3) You may forward your prescription to any pharmacy of your choice at your discretion. MizeBody provides a neutral search function without ranking, favoritism, or economic advantage for pharmacies. There are no exclusivity agreements, commissions, or other benefits.

3. Liability

3.1 Principle

Your claims for damages are excluded. Exceptions to this are your claims for damages resulting from injury to life, body, or health, or from the breach of essential contractual obligations (cardinal obligations), as well as liability for other damages resulting from our intentional or grossly negligent breach of duty, or that of our legal representatives or vicarious agents. Essential contractual obligations are those whose fulfillment is necessary to achieve the purpose of the contract.

3.2 Liability for Breach of Essential Contractual Obligations

In the event of a breach of essential contractual obligations, we are only liable for the typical, foreseeable damage if caused by simple negligence, unless it concerns claims for damages resulting from injury to life, body, or health.

3.3 Legal Representatives, Vicarious Agents; Fraud; Product Liability Act

The limitations in sections 3.1 and 3.2 also apply in favor of our legal representatives and vicarious agents when claims are asserted directly against them. The liability limitations resulting from sections 3.1 and 3.2 do not apply if we have fraudulently concealed a defect or have assumed a guarantee for the quality of the item. The same applies if we have made an agreement with you regarding the quality of the item. In addition, the provisions of other mandatory statutory regulations, e.g., those arising from statutory liability for defects or hazards, remain unaffected.

4. Data Protection

(1) We, the treating Platform Doctor, and your Preferred Pharmacy process your personal and health data (hereinafter collectively referred to as “Personal Data”) exclusively in accordance with the applicable statutory data protection provisions of the EU General Data Protection Regulation ("GDPR") and the German Federal Data Protection Act ("BDSG"), as well as the regulations applicable at the location of the Platform Doctor or Preferred Pharmacy, each as data controllers (§ 4 No. 7 GDPR) for their own business purposes. (2) The processing of your Personal Data by us takes place for the purpose and duration of initiating and carrying out the usage and mediation contract concluded with you, to provide you with your Patient Account and the platform functionalities, and in part only based on your consent (e.g., forwarding your prescription to your Preferred Pharmacy) and/or due to our legitimate interests in smooth platform operation and receivables management/collection on behalf of the Platform Doctor. The legal bases are Art. 6 para. 1 sentence 1 lit. a), b), f), Art. 9 para. 2 lit. a) GDPR. To the extent we process Personal Data for analysis and marketing purposes during platform use, this occurs only based on your consent (legal bases: Art. 6 para. 1 sentence 1 lit. a) and Art. 9 para. 2 lit. a) GDPR) or our legitimate interest (e.g., in marketing to existing customers via email for our own similar goods and services, § 7 para. 3 UWG). Further information on data protection can be found in our privacy policy, available at: https://mizebody.me/datenschutz/

5. Final Provisions

5.1 Applicable Law

The law of the Federal Republic of Germany applies, excluding the United Nations Convention on Contracts for the International Sale of Goods of 11 April 1980 (CISG), except for the mandatory provisions of the country in which you have your habitual residence.

5.2 Jurisdiction

If you do not have a general place of jurisdiction or residence in the Federal Republic of Germany or your habitual residence is unknown at the time of filing a lawsuit, our business location shall be deemed the exclusive – including international – place of jurisdiction for all disputes arising directly or indirectly from the contractual relationship with us.

5.3 Customer Service

You can reach our customer service (no medical or pharmaceutical advice) Monday to Friday from 8:00 a.m. to 6:00 p.m. German time via e-mail at [email protected].

5.4 Online Dispute Resolution

The European Commission provides a platform for online dispute resolution (ODR), which you can find at https://ec.europa.eu/consumers/odr. We are neither obliged nor willing to participate in dispute resolution proceedings before a consumer arbitration board. Our e-mail address can be found in Section 1.1. Version of these Terms and Conditions: August 2025 MizeBody Your platform for personalized digital consultation. MizeBody is a digital platform for individual consultation and support. The content of this website is for informational purposes only and does not constitute medical advice. The use of digital consultation services does not replace a personal medical examination. Please always consult a qualified professional in case of health complaints.